# MSA Safety Inc: Form 10-Q for the period ended Sep 30, 2019

- Company: [MSA Safety Inc](/companies/msa.md) (CIK 66570)
- Form: 10-Q
- Filed: 2019-10-24
- Accepted by EDGAR: Oct 24, 2019, 15:11 ET
- Period: 2019-09-30
- Accession: 0000066570-19-000050
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/66570/000006657019000050/a10q-q32019.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/66570/000006657019000050/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2019-09-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2019-07-01 to 2019-09-30 | $351.0m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months, 2019-01-01 to 2019-09-30 | $1.03bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months, 2019-07-01 to 2019-09-30 | $192.3m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months, 2019-01-01 to 2019-09-30 | $557.0m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months, 2019-07-01 to 2019-09-30 | $158.7m | us-gaap:GrossProfit |
| Gross profit | 9 months, 2019-01-01 to 2019-09-30 | $469.8m | us-gaap:GrossProfit |
| Research and development | 3 months, 2019-07-01 to 2019-09-30 | $13.5m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months, 2019-01-01 to 2019-09-30 | $41.5m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months, 2019-07-01 to 2019-09-30 | $82.9m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months, 2019-01-01 to 2019-09-30 | $245.3m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2019-07-01 to 2019-09-30 | $59.6m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months, 2019-01-01 to 2019-09-30 | $146.3m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2019-07-01 to 2019-09-30 | $4.3m | us-gaap:InterestExpense |
| Interest expense | 9 months, 2019-01-01 to 2019-09-30 | $11.1m | us-gaap:InterestExpense |
| Income tax | 3 months, 2019-07-01 to 2019-09-30 | $15.7m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months, 2019-01-01 to 2019-09-30 | $37.9m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2019-07-01 to 2019-09-30 | $42.2m | us-gaap:NetIncomeLoss |
| Net income | 9 months, 2019-01-01 to 2019-09-30 | $105.3m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2019-07-01 to 2019-09-30 | $1.08 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months, 2019-01-01 to 2019-09-30 | $2.69 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2019-07-01 to 2019-09-30 | $1.09 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months, 2019-01-01 to 2019-09-30 | $2.72 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2019-07-01 to 2019-09-30 | 39,144,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months, 2019-01-01 to 2019-09-30 | 39,130,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months, 2019-01-01 to 2019-09-30 | $88.3m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months, 2019-01-01 to 2019-09-30 | $23.5m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 9 months, 2019-01-01 to 2019-09-30 | $47.2m | us-gaap:PaymentsOfDividends |
| Cash and equivalents | at 2019-09-30 | $108.5m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2019-09-30 | $686.4m | us-gaap:AssetsCurrent |
| Total assets | at 2019-09-30 | $1.70bn | us-gaap:Assets |
| Current liabilities | at 2019-09-30 | $262.2m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2019-09-30 | $990.8m | us-gaap:Liabilities |
| Long-term debt | at 2019-09-30 | $352.1m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2019-09-30 | $20.0m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | at 2019-09-30 | $702.1m | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 45,100 characters.

*The following discussion and analysis should be read in conjunction with the historical financial statements and other financial information included elsewhere in this quarterly report on Form 10-Q. This discussion may contain forward-looking statements that involve risks and uncertainties. The forward-looking statements are not historical facts, but rather are based on current expectations, estimates, assumptions and projections about our industry, business and future financial results. Our actual results could differ materially from the results contemplated by these forward-looking statements due to a number of factors, including those discussed in the sections of our annual report entitled “Forward-Looking Statements” and “Risk Factors.”*

### BUSINESS OVERVIEW

We are a global leader in the development, manufacture and supply of safety products that protect people and facility infrastructures. Many MSA products integrate a combination of electronics, mechanical systems and advanced materials to protect users against hazardous or life-threatening situations. The Company's comprehensive product line is used by workers around the world in a broad range of markets, including the oil, gas and petrochemical ("OGP"), fire service, construction, utilities and mining industries. MSA's core products include fixed gas and flame detection systems, breathing apparatus where self-contained breathing apparatus ("SCBA") is the principal product, portable gas detection instruments, industrial head protection products, firefighter helmets and protective apparel, and fall protection devices. We are committed to providing our customers with service unmatched in the safety industry and, in the process, enhancing our ability to provide a growing line of safety solutions for customers in key global markets.

On May 20, 2019, the Company acquired 100% of the common stock of Sierra Monitor Corporation ("SMC") in an all-cash transaction valued at $33.2 million, net of cash acquired. Based in Milpitas, California, in the heart of Silicon Valley, SMC is a leading provider of fixed gas and flame detection instruments and Industrial Internet of Things solutions that connect and help protect high-value infrastructure assets. The acquisition enables MSA to accelerate its strategy to enhance worker safety and accountability through the use of cloud technology and wireless connectivity; a key focus of the company's recently established Safety ioTM subsidiary. MSA launched Safety ioTM in 2018, primarily to leverage the capabilities of its portable gas detection portfolio as it relates to cloud connectivity. The transaction was funded through borrowings on our unsecured senior revolving credit facility. Refer to Note—19 Acquisitions to the unaudited condensed consolidated financial statements in Part I Item 1 of this Form 10-Q for further information.

We tailor our product offerings and distribution strategy to satisfy distinct customer preferences that vary across geographic regions. To best serve these customer preferences, we have organized our business into six geographical operating segments that are aggregated into three reportable geographic segments: Americas, International and Corporate. In 2018, 63% and 37% of our net sales were made by our Americas and International segments, respectively.

*Americas*. Our largest manufacturing and research and development facilities are located in the United States (U.S.). We serve our markets across the Americas with manufacturing facilities in the U.S., Mexico and Brazil. Operations in other Americas segment countries focus primarily on sales and distribution in their respective home country markets.

*International*. Our International segment includes companies in Europe, the Middle East, Africa and the Asia Pacific region, some of which are in developing regions of the world. In our largest International affiliates (in Germany, France, United Kingdom (U.K.), Ireland and China), we develop, manufacture and sell a wide variety of products. In China, the products manufactured are sold primarily in the home country as well as in regional markets. Operations in other International segment countries focus primarily on sales and distribution in their respective home country markets. Although some of these companies may perform limited production, most of their sales are of products manufactured in our plants in Germany, France, the U.S., U.K., Ireland and China, or are purchased from third-party vendors. During the nine months ended September 30, 2019, a plan to close our South Africa affiliates was approved as part of our footprint rationalization, but we will continue to serve the Africa region through our channel partners.

*Corporate*. The Corporate segment primarily consists of general and administrative expenses incurred in our corporate headquarters, costs associated with corporate development initiatives, legal expense, interest expense, foreign exchange gains or losses and other centrally-managed costs. Corporate general and administrative costs comprise the majority of the expense in the Corporate segment.

### PRINCIPAL PRODUCTS

The following is a brief description of each of our principal product categories:

MSA's corporate strategy includes a focus on driving sales of core products where we have leading market positions and a distinct competitive advantage. Core products, as mentioned above, include fixed gas and flame detection instruments, breathing apparatus where SCBA is the principal product, portable gas detection instruments, industrial head protection products, firefighter helmets and protective apparel, and fall protection devices. These products receive the highest levels of investment and resources as they typically realize higher levels of return on investment than non-core products. Core products comprised approximately 87% and 86% of sales for the nine months ended September 30, 2019 and 2018, respectively.

MSA maintains a portfolio of non-core products. Non-core products reinforce and extend the core offerings, drawing upon our customer relationships, distribution channels, geographical presence and technical experience. These products are complementary to the core offerings and have their roots within the core product value chain. Key non-core products include respirators, eye and face protection, ballistic helmets and gas masks. Ballistic helmet and gas mask sales are the primary sales to our military customers and were approximately $27.0 million and $32.6 million globally during the nine months ended September 30, 2019 and 2018, respectively.

A detailed listing of our significant product offerings in the aforementioned product groups above is included in MSA's Annual Report on Form 10-K for the year ended December 31, 2018.

### RESULTS OF OPERATIONS

### Three Months Ended September 30, 2019, Compared to Three Months Ended September 30, 2018

***Net Sales.*** Net sales for the three months ended September 30, 2019, were $351.0 million, an increase of $19.9 million, or 6.0% compared to $331.1 million for the three months ended September 30, 2018. Please refer to the Net Sales table for a reconciliation of the quarter over quarter sales change.

*(In millions)*

| Net Sales | Three Months Ended September 30, 2019 | 2018 | Dollar Increase | Percent Increase |
| --- | ---: | ---: | ---: | ---: |
| **Consolidated** | **$351.0** | **$331.1** | **$19.9** | 6.0% |
| Americas | 234.6 | 209.3 | 25.3 | 12.1% |
| International | 116.4 | 121.8 | (5.4) | (4.4)% |

| Net Sales (Percent Change) | Three Months Ended September 30, 2019 versus September 30, 2018 Americas | International | Consolidated |
| --- | ---: | ---: | ---: |
| **GAAP reported sales change** | **12.1%** | **(4.4)%** | **6.0%** |
| Currency translation effects | 0.4% | 3.4% | 1.6% |
| Constant currency sales change | 12.5% | (1.0)% | 7.6% |

Note: Constant currency sales change is a non-GAAP financial measure provided by the Company to give a better understanding of the Company's underlying business performance. Constant currency sales change is calculated by deducting the percentage impact from currency translation effects from the overall percentage change in net sales.

Net sales for the Americas segment were $234.6 million in the third quarter of 2019, an increase of $25.3 million, or 12.1%, compared to $209.3 million in the third quarter of 2018, on stronger core sales. During the quarter, constant currency sales in the Americas segment increased 12.5% compared to the prior year period, driven primarily by growth in industrial personal protective equipment, gas detection and air purifying respirators ("APR"). Breathing apparatus sales declined year over year due to delays in product certification for all firefighting breathing apparatus manufacturers, which delayed the launch of our next generation G1 SCBA by approximately six weeks. We began shipping the new G1 SCBA immediately upon receipt of the certification on September 30, 2019. The impact of lower breathing apparatus volumes in the quarter was mostly offset by revenue growth in firefighter helmets and protective apparel.

Net sales for the International segment were $116.4 million in the third quarter of 2019, a decrease of $5.4 million, or 4.4%, compared to $121.8 million for the third quarter of 2018. Constant currency sales in the International segment decreased 1.0% during the quarter as stronger core sales across our industrial and gas detection portfolio were offset by lower breathing apparatus sales and weaker non-core sales primarily in Europe on lower ballistic helmet sales. The decline in breathing apparatus sales year over year was primarily driven by a large order in our Pacific Asia region that shipped in the second half of 2018.

Refer to Note 8—Segment Information to the unaudited condensed consolidated financial statements in Part I Item I of this Form 10-Q, for information regarding sales by product group.

***Gross profit.*** Gross profit for the third quarter of 2019 was $158.7 million, an increase of $10.4 million or 7.0%, compared to $148.3 million for the third quarter of 2018. The ratio of gross profit to net sales was 45.2% in the third quarter of 2019 compared to 44.8% in the same quarter last year. The higher gross profit ratio during the current quarter is primarily attributable to new product launches and pricing initiatives.

***Selling, general and administrative expenses.*** Selling, general and administrative ("SG&A") expenses were $82.9 million during the third quarter of 2019, an increase of $4.9 million or 6.3%, compared to $78.0 million in the third quarter of 2018. Overall, selling, general and administrative expenses were 23.6% of net sales in both the third quarter of 2019 and third quarter of 2018.

Please refer to the Selling, general and administrative expenses table for a reconciliation of the period over period expense change.

| Selling, general, and administrative expenses (Percent Change) | Three Months Ended September 30, 2019 versus September 30, 2018 Consolidated |
| --- | ---: |
| GAAP reported change | 6.3% |
| Currency translation effects | 1.7% |
| Constant currency change | 8.0% |
| Less: Acquisitions and related strategic transaction costs | (4.0)% |
| Organic constant currency change | 4.0% |

Note: Organic constant currency change is a non-GAAP financial measure provided by the Company to give a better understanding of the Company's underlying business performance. Organic constant currency change in selling, general, and administrative expenses is calculated by deducting the percentage impact from acquisitions and related strategic transaction costs as well as the currency translation effects from the overall percentage change in selling, general, and administrative expense. Management believes excluding acquisitions and currency translation effects provides investors with a greater level of clarity into spending levels on a year-over-year basis.

***Research and development expense.*** Research and development expense was $13.5 million during the third quarter of 2019, an increase of $0.2 million, compared to $13.3 million during the third quarter of 2018. Research and development expense was 3.9% of net sales in the third quarter of 2019 compared to 4.0% in the same period of 2018. We continue to develop new products for global safety markets, including the upcoming launch of the Altair io 360, which is a first-of-its-kind gas detection for area monitoring and the V-Gard H1 Safety Helmet, which is the next generation of head protection. During the third quarter of 2019, we capitalized $1.5 million of software development costs.

***Restructuring charges.*** During the third quarter of 2019, the Company recorded restructuring charges of $1.9 million, primarily related to footprint rationalization and other restructuring programs associated with our ongoing initiatives to drive profitable growth in our International segment. This compared to restructuring charges of $2.6 million during the third quarter of 2018, primarily related to severance costs for staff reductions in our Northern North America region as well as staff reductions associated with our ongoing initiatives to drive profitable growth in Europe and the legal and operational realignment of our U.S. and Canadian operations.

***Currency exchange.*** Currency exchange gains were $0.9 million in the third quarter of 2019 compared to $0.3 million in the third quarter of 2018. Currency exchange gains in both periods were related to foreign currency exposure on unsettled inter-company balances. Refer to Note 16—Derivative Financial Instruments to the unaudited condensed consolidated financial statements in Part I Item I of this Form 10-Q, for information regarding our currency exchange rate risk management strategy.

***Product liability expense.*** Product liability expense for the three months ended September 30, 2019 was $1.7 million related primarily to defense costs incurred for uninsured asserted cumulative trauma product liability claims as compared to $14.6 million during the same period in 2018 related primarily to an increase in our estimate for asserted cumulative trauma product liability reserve as well as defense costs incurred.

***GAAP operating income.*** Consolidated operating income for the third quarter of 2019 was $59.6 million compared to consolidated operating income of $40.0 million in the same period last year. The increase in operating results was primarily driven by higher sales volumes as discussed above as well as lower product liability expense.

***Adjusted operating income.*** Americas adjusted operating income for the third quarter of 2019 was $59.0 million, an increase of $7.5 million, or 14%, compared to $51.5 million in the prior year quarter. The increase was related to the higher level of sales and margin expansion driven primarily by new product launches and pricing initiatives.

International adjusted operating income for the third quarter of 2019 was $13.8 million, an increase of $0.5 million, or 3%, compared to $13.3 million in the prior year quarter. The increase in adjusted operating income is primarily attributable to improved leverage of SG&A driven by our cost reduction programs partially offset by a lower level of sales volumes.

Corporate segment adjusted operating loss for the third quarter of 2019 was $9.5 million, an increase of $1.7 million, or 22%, compared to an adjusted operating loss of $7.8 million in the third quarter of 2018 due to increased professional service expenses.

The following tables represent a reconciliation from GAAP operating income to adjusted operating income (loss) and adjusted EBITDA. Adjusted operating margin % is calculated as adjusted operating income (loss) divided by net sales and adjusted EBITDA margin % is calculated as adjusted EBITDA divided by net sales.

*(In thousands)*

| Adjusted operating income | Three Months Ended September 30, 2019 Americas | International | Corporate | Consolidated |
| --- | ---: | ---: | ---: | ---: |
| Net sales | $234,624 | $116,390 | — | $351,014 |
| GAAP operating income |  |  |  | 59,614 |
| Restructuring charges (Note 4) |  |  |  | 1,850 |
| Currency exchange gains, net (Note 6) |  |  |  | (913) |
| Product liability expense (Note 18) |  |  |  | 1,730 |
| Strategic transaction costs (Note 19) |  |  |  | 952 |
| Adjusted operating income (loss) | 58,971 | 13,776 | (9,514) | 63,233 |
| Adjusted operating margin % | 25.1% | 11.8% |  |  |
| Depreciation and amortization |  |  |  | 9,547 |
| Adjusted EBITDA | 65,342 | 16,854 | (9,416) | 72,780 |
| Adjusted EBITDA % | 27.8% | 14.5% |  |  |

- 35-

*(In thousands)*

| Adjusted operating income | Three Months Ended September 30, 2018 Americas | International | Corporate | Consolidated |
| --- | ---: | ---: | ---: | ---: |
| Net sales | $209,343 | $121,753 | — | $331,096 |
| GAAP operating income |  |  |  | 40,003 |
| Restructuring charges (Note 4) |  |  |  | 2,615 |
| Currency exchange gains, net (Note 6) |  |  |  | (252) |
| Product liability expense (Note 18) |  |  |  | 14,627 |
| Strategic transaction costs (Note 19) |  |  |  | 56 |
| Adjusted operating income (loss) | 51,532 | 13,329 | (7,812) | 57,049 |
| Adjusted operating margin % | 24.6% | 10.9% |  |  |
| Depreciation and amortization |  |  |  | 9,378 |
| Adjusted EBITDA | 57,573 | 16,559 | (7,705) | 66,427 |
| Adjusted EBITDA % | 27.5% | 13.6% |  |  |

Note: Adjusted operating income (loss) and adjusted EBITDA are a non-GAAP financial measures used by the chief operating decision maker to evaluate segment performance and allocate resources. Adjusted operating income (loss) is reconciled above to the nearest GAAP financial measure, Operating income (loss), and excludes restructuring, currency exchange, product liability expense and strategic transaction costs. Adjusted EBITDA is reconciled above to the nearest GAAP financial measure, Operating income (loss) and excludes depreciation and amortization expense.

***Total other expense, net.*** Total other expense, net, for the third quarter of 2019 was $1.3 million, compared to $1.7 million for the same period in 2018, primarily due to the absence of the loss on extinguishment of debt recognized in third quarter of 2018.

***Income taxes.*** The reported effective tax rate for the third quarter of 2019 was 26.9% compared to 11.0% for the third quarter of 2018. This increase from the prior year is attributable to benefits recognized in the third quarter of 2018 related to tax reform and amended returns, as well as expenses recognized in the third quarter of 2019 related to dividend income subject to income taxes in foreign jurisdictions and a reduction in the benefit related to domestic goods sold into foreign markets.

***Net income attributable to MSA Safety Incorporated.*** Net income was $42.2 million for the third quarter of 2019, or $1.08 per diluted share compared to income of $33.7 million, or $0.86 per diluted share, for the same period last year.

### Nine Months Ended September 30, 2019, Compared to Nine Months Ended September 30, 2018

***Net Sales.*** Net sales for the nine months ended September 30, 2019, were $1,026.7 million compared to $996.3 million for the nine months ended September 30, 2018. Please refer to the Net Sales table for a reconciliation of the period over period sales change.

*(In millions, except percentage amounts)*

| Net Sales | Nine Months Ended September 30, 2019 | 2018 | Dollar Increase/ (Decrease) | Percent Increase/(Decrease) |
| --- | ---: | ---: | ---: | ---: |
| **Consolidated** | **$1,026.7** | **$996.3** | **$30.4** | **3.1%** |
| Americas | 679.7 | 633.8 | 45.9 | 7.2% |
| International | 347.0 | 362.5 | (15.5) | (4.3)% |

| Net Sales (Percent Change) | Nine Months Ended September 30, 2019 versus September 30, 2018 Americas | International | Consolidated |
| --- | ---: | ---: | ---: |
| **GAAP reported sales change** | **7.2%** | **(4.3)%** | **3.1%** |
| Currency translation effects | 0.8% | 5.2% | 2.4% |
| Constant currency sales change | 8.0% | 0.9% | 5.5% |

Note: Constant currency sales change is a non-GAAP financial measure provided by the Company to give a better understanding of the Company's underlying business performance. Constant currency sales change is calculated by removing the percentage impact of currency translation effects from the overall percentage change in net sales.

Net sales for the Americas segment were $679.7 million for the nine months ended September 30, 2019, an increase of $45.9 million, or 7.2%, compared to $633.8 million for the same period in 2018, due to stronger core product sales. During the nine months ended September 30, 2019, constant currency sales in the Americas segment increased 8.0% compared to the prior year period, driven primarily by growth across our portfolio with notable strength in fixed gas and flame detection and fall protection.

Net sales for the International segment were $347.0 million for the nine months ended September 30, 2019, a decrease of $15.5 million, or 4.3%, compared to $362.5 million for the same period in 2018. During the nine months ended September 30, 2019, constant currency sales in the International segment increased 0.9% compared to the prior year period, as we recognized higher sales throughout our industrial and gas detection product portfolio partially offset by lower breathing apparatus sales and weaker non-core sales primarily in Europe on lower ballistic helmet sales. The decline in breathing apparatus sales year over year was primarily driven by a large non-recurring order in our Pacific Asia region during 2018.

Refer to Note 8—Segment Information to the unaudited condensed consolidated financial statements in Part I Item I of this Form 10-Q, for information regarding sales by product group.

We continue to target mid-single digit constant currency revenue growth for 2019.

***Gross profit.*** Gross profit for the nine months ended September 30, 2019, was $469.8 million, an increase of $20.3 million, or 5%, compared to $449.5 million for the same period in 2018. The ratio of gross profit to net sales was 45.8% during the nine months ended September 30, 2019, compared to 45.1% in the same period last year. The higher gross profit ratio during the current period is primarily attributable to new product launches and pricing initiatives.

***Selling, general and administrative expenses.*** Selling, general and administrative ("SG&A") expenses were $245.3 million during the nine months ended September 30, 2019, an increase of $5.1 million or 2.1%, compared to $240.2 million during the same period in 2018. Overall, SG&A expenses were 23.9% of net sales during the nine months ended September 30, 2019, compared to 24.1% of net sales during the same period in 2018.

Please refer to the Selling, general and administrative expenses table for a reconciliation of the period over period expense change.

| Selling, general, and administrative expenses (Percent Change) | Nine Months Ended September 30, 2019 versus September 30, 2018 Consolidated |
| --- | ---: |
| GAAP reported change | 2.1% |
| Currency translation effects | 2.4% |
| Constant currency change | 4.5% |
| Less: Acquisitions and related strategic transaction costs | (2.7)% |
| Organic constant currency change | 1.8% |

Note: Organic constant currency change is a non-GAAP financial measure provided by the Company to give a better understanding of the Company's underlying business performance. Organic constant currency change in selling, general, and administrative expenses is calculated by deducting the percentage impact from acquisitions and related strategic transaction costs as well as the currency translation effects from the overall percentage change in selling, general, and administrative expense. Management believes excluding acquisitions and currency translation effects provides investors with a greater level of clarity into spending levels on a year-over-year basis.

***Research and development expense.*** Research and development expense was $41.5 million during the nine months ended September 30, 2019, an increase of $1.7 million, or 4%, compared to $39.8 million during the same period in 2018. Research and development expense was 4.0% of net sales during both the nine months ended September 30, 2019 and 2018. We continue to develop new products for global safety markets, including the newly unveiled MSA connected firefighter product powered by LUNAR, which was introduced in early 2019, as well as the upcoming launch of the Altair io 360, which is a first-of-its-kind gas detection for area monitoring and the V-Gard H1 Safety Helmet, which is the next generation of head protection. During nine months ended September 30, 2019, we capitalized $3.5 million of software development costs.

***Restructuring charges.*** During the nine months ended September 30, 2019, the Company recorded restructuring charges of $11.2 million, primarily related to footprint rationalization and other restructuring programs associated with our ongoing initiatives to drive profitable growth in our International segment. These programs will continue to be executed in the fourth quarter of 2019. These activities are expected to provide $7 million to $8 million of annual savings, beginning in late 2019 and continuing into 2020. Additionally, we recognized a non-cash settlement charge associated with the closure of our pension plan in the U.K. This compared to restructuring charges of $10.2 million during the same period in 2018, primarily related to severance costs for staff reductions associated with our ongoing initiatives to drive profitable growth in Europe and the legal and operational realignment of our U.S. and Canadian operations.

***Currency exchange.*** Currency exchange losses were $17.3 million in the nine months ended September 30, 2019, compared to $2.6 million during the same period in 2018. The increase in currency exchange losses was primarily due to the recognition of non-cash cumulative translation losses of approximately $15.4 million as a result of the approval of our plan to close our South Africa affiliates during the first quarter of 2019. This charge is related to the historical translation of the elements of the financial statements for the business from the functional currency to the U.S. Dollar. The translation impact has been historically recorded as currency translation adjustment (“CTA”), a separate component of accumulated other comprehensive loss within the equity section of the unaudited Condensed Consolidated Balance Sheet. The remaining currency exchange losses in both periods were related to foreign currency exposure on unsettled inter-company balances. Refer to Note 16—Derivative Financial Instruments to the unaudited condensed consolidated financial statements in Part I Item I of this Form 10-Q for information regarding our currency exchange rate risk management strategy.

***Product liability expense.*** Product liability expense for the nine months ended September 30, 2019, was $8.2 million, which related primarily to defense costs incurred for uninsured asserted cumulative trauma product liability claims. This compared to $25.5 million during the same period in 2018, which relates primarily to an increase in our estimate for asserted cumulative trauma product liability reserve in the third quarter as well as defense costs incurred and an adjustment to our estimated insurance receivables.

***GAAP operating income.*** Consolidated operating income for the nine months ended September 30, 2019, was $146.3 million compared to operating income of $131.2 million in the same period in 2018. The increase in operating results was driven by higher sales volumes and lower product liability expense as disclosed above partially offset by higher currency exchange losses.

***Adjusted operating income.*** Americas adjusted operating income for the nine months ended September 30, 2019, was $171.5 million, an increase of $20.0 million, or 13%, compared to $151.5 million during the same period in 2018. The increase was related to the higher level of sales and margin expansion driven primarily by new product launches and pricing initiatives as well as improved leverage of SG&A.

International adjusted operating income for the nine months ended September 30, 2019, was $39.9 million, a decrease of $2.1 million, or 5%, compared to $42.0 million during the same period in 2018. The decrease in adjusted operating income is primarily attributable to a lower level of sales volumes.

Corporate segment adjusted operating loss for the nine months ended September 30, 2019, was $25.5 million, an increase of $1.8 million, or 7%, compared to an adjusted operating loss of $23.7 million during the same period in 2018 due to increased professional service expenses.

The following tables represent a reconciliation from GAAP operating income to adjusted operating income (loss) and adjusted EBITDA. Adjusted operating margin % is calculated as adjusted operating income (loss) divided by net sales and adjusted EBITDA margin % is calculated as adjusted EBITDA divided by net sales.

*(In thousands, except percentage amounts)*

| Adjusted operating income | Nine Months Ended September 30, 2019 Americas | International | Corporate | Consolidated |
| --- | ---: | ---: | ---: | ---: |
| Net sales | $679,699 | $347,027 | $— | $1,026,726 |
| GAAP operating income |  |  |  | 146,252 |
| Restructuring charges (Note 4) |  |  |  | 11,203 |
| Currency exchange losses, net (Note 6) |  |  |  | 17,338 |
| Product liability expense (Note 18) |  |  |  | 8,155 |
| Strategic transaction costs (Note 19) |  |  |  | 2,937 |
| Adjusted operating income (loss) | 171,463 | 39,888 | (25,466) | 185,885 |
| Adjusted operating margin % | 25.2% | 11.5% |  |  |
| Depreciation and amortization |  |  |  | 28,339 |
| Adjusted EBITDA | 190,084 | 49,313 | (25,173) | 214,224 |
| Adjusted EBITDA % | 28.0% | 14.2% |  |  |

*(In thousands, except percentage amounts)*

| Adjusted operating income | Nine Months Ended September 30, 2018 Americas | International | Corporate | Consolidated |
| --- | ---: | ---: | ---: | ---: |
| Net sales | $633,812 | $362,508 | $— | $996,320 |
| GAAP operating income |  |  |  | 131,235 |
| Restructuring charges (Note 4) |  |  |  | 10,223 |
| Currency exchange losses, net (Note 6) |  |  |  | 2,571 |
| Product liability expense (Note 18) |  |  |  | 25,469 |
| Strategic transaction costs (Note 19) |  |  |  | 208 |
| Adjusted operating income (loss) | 151,456 | 41,960 | (23,710) | 169,706 |
| Adjusted operating margin % | 23.9% | 11.6% |  |  |
| Depreciation and amortization |  |  |  | $28,585 |
| Adjusted EBITDA | $169,691 | $52,001 | $(23,401) | $198,291 |
| Adjusted EBITDA % | 26.8% | 14.3% |  |  |

Note: Adjusted operating income (loss) and adjusted EBITDA are a non-GAAP financial measures used by the chief operating decision maker to evaluate segment performance and allocate resources. Adjusted operating income (loss) is reconciled above to the nearest GAAP financial measure, Operating income (loss), and excludes restructuring, currency exchange, product liability expense and strategic transaction costs. Adjusted EBITDA is reconciled above to the nearest GAAP financial measure, Operating income (loss) and excludes depreciation and amortization expense.

***Total other expense, net.*** Total other expense, net, during the nine months ended September 30, 2019, was $2.2 million, compared to $7.7 million during the same period in 2018, due to lower interest expense primarily as a result of a favorable adjustment related to a foreign uncertain tax position for which the statute of limitations has expired and the absence of the loss on extinguishment of debt recognized in 2018. We expect full-year 2019 interest expense to be between $14 million and $16 million.

***Income taxes.*** The reported effective tax rate for the nine months ended September 30, 2019, was 26.3%, which included an expense of 2.5% due to non-deductible foreign currency exchange losses on entity closures compared to 19.1% for the same period in 2018, which included benefits related to tax reform and amended returns.

***Net income attributable to MSA Safety Incorporated.*** Net income was $105.3 million for the nine months ended September 30, 2019, or $2.69 per diluted share compared to income of $99.3 million, or $2.55 per diluted share, for the same period last year.

### Non-GAAP Financial Information

We may provide information regarding financial measures such as organic constant currency changes, financial measures excluding the impact of acquisitions and related strategic transaction costs, adjusted operating income, adjusted operating margin percentage, adjusted EBITDA and adjusted EBITDA margin percentage, which are not recognized terms under U.S. GAAP and do not purport to be alternatives to net sales, selling, general and administrative expense, operating income or net income as a measure of operating performance. We believe that the use of these non-GAAP financial measures provide investors with additional useful information and provide a more complete understanding of the underlying results. Because not all companies use identical calculations, these presentations may not be comparable to similarly titled measures from other companies. For more information about these non-GAAP measures and a reconciliation to the nearest U.S. GAAP measure, please refer to the reconciliations referenced above in Management's Discussion & Analysis section and in Note 8—Segment Information to the unaudited condensed consolidated financial statements in Part I Item 1 of this Form 10-Q.

We may also provide financial information on a constant currency basis, which is a non-GAAP financial measure. These references to a constant currency basis do not include operational impacts that could result from fluctuations in foreign currency rates, which are outside of management's control. To provide information on a constant currency basis, the applicable financial results are adjusted by translating current and prior period results in local currency to a fixed foreign exchange rate. This approach is used for countries where the functional currency is the local country currency. This information is provided so that certain financial results can be viewed without the impact of fluctuations in foreign currency rates, thereby facilitating period-to-period comparisons of business performance. Constant currency information is not recognized under U.S. GAAP and it is not intended as an alternative to U.S. GAAP measures.

### LIQUIDITY AND CAPITAL RESOURCES

Our primary source of liquidity is operating cash flows, supplemented by borrowings. Our principal liquidity requirements are for working capital, capital expenditures, principal and interest payments on debt, dividend payments and acquisitions. At September 30, 2019, approximately 34% of our long-term debt is at fixed interest rates with repayment schedules through 2031. The remainder of our long-term debt is at variable rates on an unsecured revolving credit facility that is due in 2023. At September 30, 2019, approximately 81% of our borrowings are denominated in U.S. dollars.

At September 30, 2019, we had cash, cash equivalents and restricted cash totaling $108.9 million, which included $87.0 million of cash and cash equivalents held by our foreign subsidiaries. Cash, cash equivalents and restricted cash decreased $31.7 million during the nine months ended September 30, 2019, compared to decreasing $19.3 million during the same period in 2018. We continue to employ a balanced capital allocation strategy that prioritizes growth investments, funding our dividend and servicing debt obligations.

***Operating activities.*** Operating activities provided cash of $88.3 million during the nine months ended September 30, 2019, compared to providing $186.2 million during the same period in 2018. The decrease in operating cash flows during the period was primarily attributable to lower collections on insurance receivables and a higher use of cash for working capital to support our higher level of sales and backlog. We made product liability payments of $25.1 million, net of collections on insurance receivables, in the nine months ended September 30, 2019, compared to collecting $50.8 million from insurance companies, net of product liability settlements paid, in the same period of 2018. Historically, cumulative trauma liability payments were funded with the Company's operating cash flow, pending resolution of disputed insurance coverage. For more than a decade, we have funded product liability settlements from operating cash flow. The vast majority of the insurance receivable and notes receivable - insurance companies balances at September 30, 2019, is attributable to reimbursement believed to be due under the terms of signed agreements with insurers and are not currently subject to litigation. While the timing of cash flows for product liability and insurance receivable can and do vary from quarter to quarter, we have been successful in establishing cash flow streams that have allowed us to fund these liabilities without a material impact on our capital allocation priorities.

***Investing activities.*** Investing activities used cash of $73.8 million during the nine months ended September 30, 2019, compared to using $71.7 million during the same period in 2018. The acquisition of Sierra Monitor Corporation, purchase of short-term investments, net of proceeds from maturities and capital expenditures drove cash outflows from investing activities during the nine months ended September 30, 2019 while purchases of short-term investments and capital expenditures drove cash outflows from investing activities in the same period in 2018. During 2019, we incurred capital expenditures of $23.5 million including $3.5 million associated with software development and other growth programs. We plan to invest approximately $35 million in capital expenditures for the full year 2019.

***Financing activities.*** Financing activities used cash of $40.8 million during the nine months ended September 30, 2019, compared to using $123.9 million during the same period in 2018. During the nine months ended September 30, 2019, we had net proceeds on long-term debt of $13.0 million primarily to fund the Sierra Monitor Corporation acquisition as compared to net payments of $80.7 million during the same period in 2018. We paid cash dividends of $47.2 million during the nine months ended September 30, 2019, compared to $42.6 million in the same period in 2018. We also used cash of $3.3 million during the nine months ended September 30, 2019 to repurchase shares under our 2015 stock repurchase program.

### CUMULATIVE TRANSLATION ADJUSTMENTS

The position of the U.S. dollar relative to international currencies at September 30, 2019, resulted in a translation loss of $15.9 million being recorded to the cumulative translation adjustments shareholders' equity account during the nine months ended September 30, 2019, compared to a translation loss of $18.9 million during the same period in 2018. The translation losses during both periods were primarily related to the strengthening of the U.S. dollar relative to the euro, British pound and Brazilian real.

During the nine months ended September 30, 2019, we recognized approximately $17.3 million of currency exchange losses, net, in our unaudited Condensed Consolidated Statement of Income of which $15.1 million relates to non-cash currency exchange losses due primarily to an approved plan to close our South Africa affiliates. This charge is related to the historical translation of the elements of the financial statements for the business from the functional currency to the U.S. Dollar. The translation impact has been historically recorded as currency translation adjustment (“CTA”), a separate component of accumulated other comprehensive loss within the equity section of the unaudited Condensed Consolidated Balance Sheet.

Inflation in Argentina in the second quarter of 2018 increased at an accelerated rate and effective June 30, 2018, Argentina’s economy is considered highly inflationary. Beginning July 1, 2018, under a highly-inflationary basis of accounting, the Company’s monetary assets (such as cash and receivables) and monetary liabilities (such as payables and accruals) at its operations in Argentina are remeasured at the end of each reporting period with such entries recorded to the unaudited Condensed Consolidated Statement of Income rather than to accumulated other comprehensive loss on the unaudited Condensed Consolidated Balance Sheet. Because the Argentinian peso is subject to fluctuation, such remeasurement will increase the volatility of reported results of operations in future periods. However, as the Company has a small presence, including one manufacturing plant in the country, the impact from the highly-inflationary basis of accounting is not material to our unaudited condensed consolidated financial statements.

Brexit has caused, and may continue to create, volatility in global stock markets and regional and global economic uncertainty particularly in the U.K. financial and banking markets. Weakening of economic conditions or economic uncertainties tend to harm our business, and if such conditions worsen in the U.K. or in the rest of Europe, it may have an adverse effect on our consolidated operations and sales. The Company continues to monitor the economic situation related to Brexit and current analysis indicates that exposure in our supply chain related to additional duties and sourcing costs is not material. We have approximately $45 million of annual sales denominated in the British pound which are subject to exchange rate risk associated with any volatility in the British pound. We have long-term debt of $72.6 million at September 30, 2019, that is denominated in British pounds. Because the debt is denominated in local currency, the value of the debt and local cash flows are aligned with respect to movements in the exchange rate between the British pound and U.S. dollar.

### COMMITMENTS AND CONTINGENCIES

We made contributions of $5.3 million to our pension plans during the nine months ended September 30, 2019. We expect to make total contributions of approximately $7.1 million to our pension plans in 2019 which are primarily associated with our International segment.

The Company had outstanding bank guarantees and standby letters of credit with banks as of September 30, 2019, totaling $8.9 million, of which $2.4 million related to the senior revolving credit facility. These letters of credit serve to cover customer requirements in connection with certain sales orders and insurance companies. The Company is also required to provide cash collateral in connection with certain arrangements. At September 30, 2019, the Company has $0.4 million of restricted cash in support of these arrangements.

We have purchase commitments for materials, supplies, services, and property, plant and equipment as part of our ordinary conduct of business.

Please refer to Note 18—Contingencies to the unaudited condensed consolidated financial statements in Part I Item 1 of this Form 10-Q for further discussion on the Company's single incident and cumulative trauma product liabilities.

### CRITICAL ACCOUNTING POLICIES AND ESTIMATES

We prepare our consolidated financial statements in accordance with accounting principles generally accepted in the United States of America (U.S. GAAP). The preparation of these consolidated financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and the related disclosures. We evaluate these estimates and judgments on an on-going basis based on historical experience and various assumptions that we believe to be reasonable under the circumstances. However, different amounts could be reported if we had used different assumptions and in light of different facts and circumstances. Actual amounts could differ from the estimates and judgments reflected in our condensed consolidated financial statements.

The more critical judgments and estimates used in the preparation of our consolidated financial statements are discussed in Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations in our Annual Report on Form 10-K for the year ended December 31, 2018.

Refer to Note 14—Leases to the unaudited condensed consolidated financial statements for an update to the accounting policy for leases as a result of the adoption of ASU 2016-02, *Leases*, on January 1, 2019.

### RECENTLY ADOPTED AND RECENTLY ISSUED ACCOUNTING STANDARDS

Please refer to Note 2— Recently Adopted and Recently Issued Accounting Standards to the unaudited condensed consolidated financial statements in Part I Item 1 of this Form 10-Q.

## Market risk

As filed, 2,330 characters.

Market risk represents the risk of adverse changes in the value of a financial instrument caused by changes in currency exchange rates, interest rates and equity prices. We are exposed to market risks related to currency exchange rates and interest rates.

***Currency exchange rate sensitivity.*** We are subject to the effects of fluctuations in currency exchange rates on various transactions and on the translation of the reported financial position and operating results of our non-U.S. companies from local currencies to U.S. dollars. A hypothetical 10% strengthening or weakening of the U.S. dollar would decrease or increase our reported sales and net income by approximately $15.3 million or 4.4% and $1.3 million or 3.0%, respectively, for the three months ended September 30, 2019.

When appropriate, we may attempt to limit our transactional exposure to changes in currency exchange rates through contracts or other actions intended to reduce existing exposures by creating offsetting currency exposures. At September 30, 2019, we had open foreign currency forward contracts with a U.S. dollar notional value of $75.7 million. A hypothetical 10% strengthening or weakening of the U.S. dollar would result in a $7.6 million increase or decrease in the fair value of these contracts at September 30, 2019.

***Interest rates.*** We are exposed to changes in interest rates primarily as a result of borrowing and investing activities used to maintain liquidity and fund business operations.

At September 30, 2019, we had $127.5 million of fixed rate debt which matures at various dates through 2031. The incremental increase in the fair value of fixed rate long-term debt resulting from a hypothetical 10% decrease in interest rates would be approximately $9.5 million. However, our sensitivity to interest rate declines and the corresponding increase in the fair value of our debt portfolio would unfavorably affect earnings and cash flows only to the extent that we elected to repurchase or retire all or a portion of our fixed rate debt portfolio at prices above carrying values.

At September 30, 2019, we had $246.2 million of variable rate borrowings under our revolving credit facility. A 100 basis point increase or decrease in interest rates could impact our future earnings under our current capital structure.

## Controls and procedures

As filed, 1,167 characters.

(a) *Evaluation of disclosure controls and procedures.* Based on their evaluation as of the end of the period covered by this Form 10-Q, the Company’s principal executive officer and principal financial officer have concluded that the Company’s disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934 (the “Exchange Act”)) are effective to ensure that information required to be disclosed by the Company in reports that it files or submits under the Exchange Act is (i) recorded, processed, summarized and reported within the time periods specified in Securities and Exchange Commission rules and forms and (ii) accumulated and communicated to our management, including the principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding disclosure.

(b) *Changes in internal control*. There were no changes in the Company’s internal control over financial reporting that occurred during the most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

## Risk factors

As filed, 4,091 characters.

**Claims of injuries from our products, product defects or recalls of our products could have a materially adverse effect on our business, operating results, financial condition and liquidity.**

MSA and its subsidiaries face an inherent business risk of exposure to product liability claims arising from the alleged failure of our products to prevent the types of personal injury or death against which they are designed to protect. In the event the parties using our products are injured or any of our products prove to be defective, we could be subject to claims with respect to such injuries. In addition, we may be required to or may voluntarily recall or redesign certain products that could potentially be harmful to end users. Any claim or product recall that results in significant expense or negative publicity against us could have a material adverse effect on our business, operating results, financial condition and liquidity, including any successful claim brought against us in excess or outside of available insurance coverage.

**Our subsidiary, Mine Safety Appliances Company, LLC, may experience losses from cumulative trauma product liability claims. The inability to collect insurance receivables and the transition to becoming largely self-insured for cumulative trauma product liability claims could have a material adverse effect on our business, operating results, financial condition and liquidity.**

Our subsidiary, Mine Safety Appliances Company, LLC (“MSA LLC”) was named as a defendant in 1,591 cumulative trauma lawsuits comprised of 2,493 claims at September 30, 2019. Cumulative trauma product liability claims involve exposures to harmful substances (e.g., silica, asbestos and coal dust) that occurred years ago and may have developed over long periods of time into diseases such as silicosis, asbestosis, mesothelioma or coal worker’s pneumoconiosis. The products at issue were manufactured many years ago and are not currently offered by MSA LLC. A reserve has been established with respect to cumulative trauma product liability claims currently asserted and estimated incurred but not reported (“IBNR”) cumulative trauma product liability claims. Because our cumulative trauma product liability risk is subject to inherent uncertainties, including unfavorable trial rulings or developments, an increase in newly filed claims, or more aggressive settlement demands, and since MSA LLC is largely self-insured, there can be no certainty that MSA LLC may not ultimately incur losses in excess of presently recorded liabilities. These losses could have a material adverse effect on our business, operating results, financial condition and liquidity. We will adjust the reserve relating to cumulative trauma product liability claims from time to time based on whether the actual numbers, types and settlement values of claims asserted differ from current projections and estimates or there are significant changes in the facts underlying the assumptions used in establishing the reserve. These adjustments may be material and could materially impact future periods in which the reserve is adjusted.

In the normal course of business, MSA LLC makes payments to settle these types of cumulative trauma product liability claims and for related defense costs, and records receivables for the estimated amounts believed to be recoverable under insurance. MSA LLC has recorded insurance receivables totaling $57.9 million and notes receivables of $55.6 million at September 30, 2019. Since MSA LLC is now largely self-insured for cumulative trauma claims, additional amounts recorded as insurance receivables will be limited and based on calculating the amounts to be reimbursed pursuant to negotiated Coverage-in-Place Agreements. Various factors could affect the timing and amount of recovery of the insurance receivable, including assumptions regarding claims composition (which are relevant to calculating reimbursement under the terms of certain Coverage-In-Place Arrangements) and the extent to which the issuing insurers may become insolvent in the future.

Filed Oct 24, 2019.
Source: SEC EDGAR, the filing index for accession 0000066570-19-000050. Last ingested by Listed: Nov 3, 2026, 21:35 ET. No prices; not investment advice.
